Intracellular transport of class II MHC molecules directed by invariant chain - PubMed (original) (raw)
. 1990 Dec 13;348(6302):600-5.
doi: 10.1038/348600a0.
Affiliations
- PMID: 2250716
- DOI: 10.1038/348600a0
Intracellular transport of class II MHC molecules directed by invariant chain
V Lotteau et al. Nature. 1990.
Abstract
Three structural motifs in the invariant chain (li) control the intracellular transport of class II major histocompatibility complex molecules. An endoplasmic reticulum retention signal in the full-length li suggests a role for li in the alpha-beta heterodimer assembly. Another signal motif directs a truncated li, alone or associated with individual class II chains, to a degradation compartment by a pathway circumventing the Golgi. When this truncated li binds alpha-beta dimers, a third signal dominates, directing the complex by way of the Golgi to vesicles in the cell periphery, which may represent a subcompartment of recycling endosomes.
Similar articles
- A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H, Brunet A, Thibodeau J. Khalil H, et al. J Cell Sci. 2005 Oct 15;118(Pt 20):4679-87. doi: 10.1242/jcs.02592. Epub 2005 Sep 27. J Cell Sci. 2005. PMID: 16188937 - Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA, Cresswell P. Lamb CA, et al. J Immunol. 1992 Jun 1;148(11):3478-82. J Immunol. 1992. PMID: 1588042 - Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
Germain RN. Germain RN. Semin Immunol. 1995 Dec;7(6):361-72. doi: 10.1006/smim.1995.0041. Semin Immunol. 1995. PMID: 8775462 Review. - In search of a function for the invariant chain associated with Ia antigens.
Long EO. Long EO. Surv Immunol Res. 1985;4(1):27-34. doi: 10.1007/BF02918583. Surv Immunol Res. 1985. PMID: 3890055 Review. No abstract available.
Cited by
- Hydroxychloroquine attenuates sepsis-induced acute respiratory distress syndrome in rats.
Ercan G, Bora ES, Çınaroğlu OS, Karaali R, Erbas O. Ercan G, et al. Ulus Travma Acil Cerrahi Derg. 2024 Jul;30(7):465-471. doi: 10.14744/tjtes.2024.98855. Ulus Travma Acil Cerrahi Derg. 2024. PMID: 38967533 Free PMC article. - Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy.
Kim YM, Sung JH, Cha HH, Oh SY. Kim YM, et al. Obstet Gynecol Sci. 2024 Mar;67(2):143-152. doi: 10.5468/ogs.23252. Epub 2024 Jan 19. Obstet Gynecol Sci. 2024. PMID: 38246692 Free PMC article. - Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study.
In 't Veld AE, Grievink HW, van der Plas JL, Eveleens Maarse BC, van Kraaij SJW, Woutman TD, Schoonakker M, Klarenbeek NB, de Kam ML, Kamerling IMC, Jansen MAA, Moerland M. In 't Veld AE, et al. Immunol Res. 2023 Aug;71(4):617-627. doi: 10.1007/s12026-023-09367-3. Epub 2023 Feb 22. Immunol Res. 2023. PMID: 36811819 Free PMC article. Clinical Trial. - Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system.
Jin Y, Deng Z, Zhu T. Jin Y, et al. Cancer Cell Int. 2022 Dec 17;22(1):413. doi: 10.1186/s12935-022-02805-6. Cancer Cell Int. 2022. PMID: 36528587 Free PMC article. Review. - The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules.
Sarango G, Richetta C, Pereira M, Kumari A, Ghosh M, Bertrand L, Pionneau C, Le Gall M, Grégoire S, Jeger-Madiot R, Rosoy E, Subra F, Delelis O, Faure M, Esclatine A, Graff-Dubois S, Stevanović S, Manoury B, Ramirez BC, Moris A. Sarango G, et al. EMBO Rep. 2022 Dec 6;23(12):e55470. doi: 10.15252/embr.202255470. Epub 2022 Oct 10. EMBO Rep. 2022. PMID: 36215666 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials